Background: Although a rare complication of catheter based ablation for atrial fibrillation (AF), atrioesophageal fistula (AEF) is a serious and fatal event [1e5]. Most reports of AEF are single cases or small case series. Objective: The purpose of this study was to perform a comprehensive literature search of all published atrioesophageal fistula following catheter ablation for AF in order to identify the mortality rates associated with therapeutic modalities and suggest the most definitive management in reducing mortality. Methods: A comprehensive literature review of reported observational cases of atrioesophageal fistula post catheter based ablation for atrial fibrillation was performed. Results: Sixty-five cases of AEF post atrial fibrillation ablation were reviewed. The mean age was 55 years old. 73.8% (48/65) of the identified cases occurred in males (p < 0.001). Of the 65 cases, 13 underwent surgical radiofrequency ablation (RFA) and 52 underwent percutaneous RFA. Mortality resulted in 53.8% of those who underwent surgical RFA and in 55.8% of those who underwent percutaneous RFA (p ¼ .888). The time range interval from procedure to onset of symptoms was 1e60 days. The most prevalent symptom, fever, occurred in 52 of the 65 cases, followed by neurological symptoms (n ¼ 44). CT of the chest (n ¼ 37), transthoracic echocardiogram (n ¼ 21), and CT of the head (n ¼ 18) were the preferred diagnostic modalities. Patients who underwent surgical correction with esophageal repair for treatment were more likely to survive, in comparison to patients who were treated with non-surgical interventions, such as antibiotic therapy, anticoagulation therapy or esophageal stenting. Of the total 34 patients who were treated surgically, 27 survived (79.4%). Of the total 31 patients who were treated non-surgically, only 2 survived (6.5%), reflecting significantly lower mortality with surgical versus non-surgical therapy (p < 0.001). Conclusion: Atrioesophageal fistula is an uncommon but potentially fatal complication of atrial fibrillation ablation. Patients who underwent surgical repair were twelve times more likely to survive than those treated with stenting, antibiotic therapy or no intervention. Based on the observation that patients are 12 times more likely to survive an AEF with surgery than without, the authors believe that prompt surgical correction of AEF should be considered as standard of care when dealing with this dreaded complication.
Introduction
Catheter based ablation is a common treatment option in patients who either failed or declined medical therapy for atrial fibrillation (AF). With the incidence and prevalence of atrial fibrillation increasing worldwide, the frequency of catheter based ablations also continues to rise. Ablation of AF most commonly involves creating circumferential lesions around the pulmonary vein ostia or antra with or without the placement of additional ablation lesions within the left atrium [3] . The left atrium is anterior to the esophagus [3, 4] . The close proximity of the esophagus to the (1) CT of chest Surgery left atrium makes it susceptible to potential injury during catheter based ablation of AF [7] . While the possible complication of atrioesophageal fistula is rare post catheter ablation of AF, it is, none-the-less a severe, life -threatening complication that is one of the most feared [1, 3, 6] . It is estimated to occur in 1 of 500e1000 cases [6] . The mortality rate associated with AEF has been reported to surpass 60%e80% [5, 10] .
We have reviewed the clinical characteristics, discuss diagnostic modalities and determine the most definitive treatment options available, in order to recognize and promptly treat AEF, given its fatal outcome [1] .
Methods

Search strategy
The purpose of this study was to collate cases of AEF post ablation for AF that were identified from published reports in the literature. PubMed is a searchable online database and service of the US National Library of Medicine that provides access to medical journal articles. A systemic search of the database PubMed from inception to June 2017 was performed. The search terms included "atrioesophageal fistula" or "atrio-esophageal fistula" or "esophagoatrial fistula" or "esophago-atrial fistula." These terms were searched as free text in the title or the abstract [1] . In addition, Google Scholar, another searchable online database, was systemically searched with the same terms as above. Lastly, we reviewed reference lists of bibliographies of the listed articles.
Selection criteria
Case reports selected reported: (1) the primary diagnosis as AF for ablation procedure; (2) clinical presentation; (3) diagnostic imaging; (4) management and (5) outcome [1] .
Statistical analysis
For this systemic review of case reports, we used the Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) statement protocol. Chi-squared analyses were used to determine differences in percentages between groups. Statistical significance was set at 0.05 [1] .
Results
Demographics and clinical presentation
Sixty-five cases of AEF post atrial fibrillation ablation were reviewed and compiled into a table (Table 1 ). The mean age was 55 years old. 73.8% (48/65) of the identified cases occurred in males and 26.2% (17/65) occurred in females (p < 0.001) (Fig. 1) . Of the 65 cases, 13 (20%) underwent surgical RFA and 52 (80%) underwent percutaneous RFA. Mortality resulted in 53.8% of those who underwent surgical RFA and in 55.8% of those who underwent percutaneous RFA (p < 0.888) (Fig. 2) . Given these results, there is no clinical significance in mortality between those who underwent surgical versus percutaneous radiofrequency ablation. The range CT of head Nonsurgical Death AEF, atrioesophageal fistula; AMS, altered mental status; CFAE, complex fractionated atrial electrograms; CPVA, circumferential pulmonary vein ablation; EGD, esophagoduodenoscopy; GEJ gastroesophageal junction; GI, gastrointestinal; HIFU, high-intensity focused ultrasound; IRAAF, intra-operative radiofrequency ablation of atrial fibrillation; IV, intravenous; LA, left atrium; LRFA, linear radiofrequency ablation; MVR, mitral valve replacement; NA, not available; PAD, post-ablation day; PV, pulmonary veins; PVI, pulmonary vein isolation; RFA, radiofrequency ablation; RFCA, radiofrequency catheter ablation; RSFA, right superior frontal area; TEE, transesophageal echocardiogram; TIA, transient ischemic attack; TTE, transthoracic echocardiogram; UGI, upper gastrointestinal; VF, ventricular fibrillation; WBC, white blood cells. Fig. 2 . Comparison of the number of patients with AEF who initially underwent surgical radiofrequency (RFA) versus percutaneous RFA for treatment of atrial fibrillation. Of the 65 cases, 13 (20%) underwent surgical RFA and 52 (80%) underwent percutaneous RFA. Mortality resulted in 53.8% (7/13) of those who underwent surgical RFA and in 55.8% (29/52) of those who underwent percutaneous RFA (p < 0.888). Thus, there is no difference in mortality between patients who underwent surgical RFA versus percutaneous RFA. Fig. 3 . The frequency of symptoms in patients with AEF post atrial fibrillation at the initial time of presentation. Symptoms will likely occur in a triad of fever, neurological deficits (such as hemiparesis) and/or hematemesis, all three of which make up the most frequent clinical presentations identified. interval from procedure to onset of symptoms was 1e60 days (Table 1 ) [1, 3] . Fever occurred most commonly in 52 of the 65 cases, followed by neurological symptoms such as hemiparesis, stroke/ TIA, motor and language impairment which occurred in 44 cases.
Patients also presented with hematemesis (n ¼ 21), chest pain
, melena (n ¼ 1), and odynophagia (n ¼ 1) (Fig. 3) .
Diagnostic modalities, treatment and outcome
Among the diagnostic modalities employed were CT of the chest (n ¼ 37), transthoracic echocardiogram (n ¼ 21), and CT of the head (n ¼ 18) (Fig. 4) . Air embolism was most commonly identified in 17 patients, followed by pneumomediastinum identified in 12 patients (Table 1) .
Of the total 65 cases reviewed, 36 resulted in deaths, whether surgically or non-surgically treated. Thus, the total mortality rate of all cases reviewed was 55 .4%, making atrioesophageal fistula a rare, but grave outcome post atrial fibrillation ablation.
Patients who underwent surgical correction with esophageal repair for treatment were more likely to survive, in comparison to patients who were treated with non-surgical interventions, such as antibiotic therapy, anticoagulation therapy or esophageal stenting. Mortality rates were significantly reduced in those who underwent surgical intervention at 20.6% (7/34) versus a mortality rate of 93.5% (29/31) in patients who were not treated surgically (p < 0.001) (Fig. 5 ).
Discussion
Atrioesophageal fistula, an uncommon but adverse event of atrial fibrillation catheter based ablation, is associated with a high fatality rate. The mortality rate associated with surgical RFA was 53.8% (7 deaths in a total of 13 patients who underwent surgical RFA) versus 55.8% with percutaneous RFA (29 deaths in a total of 52 patients who underwent percutaneous RFA) (p < 0.001). Thus, there is no difference in mortality between surgical RFA and percutaneous RFA.
Patients may present with non-specific symptoms, ranging from 1 to 60 days after the ablation (Fig. 6) [1, 3] . Common symptoms may include a triad of fever, neurological deficits (such as hemiparesis) and/or hematemesis [1] . Other symptoms may include chest discomfort, altered mental status, seizures, abdominal pain, nausea, vomiting, dysphagia, odynophaga, melena, and dyspnea (Fig. 3) . Given the high mortality rate, it is essential to hold a high index of clinical suspicion in patients who recently underwent ablation for AF and present with such non-specific symptoms [1, 3, 7] .
The most common diagnostic modality for identifying AEF following AF ablation includes CT of the chest, TTE and CT of the head. Other methods of imaging used included esophogram, MRI of the brain, TEE, CT of the abdomen or pelvis, and Cardiac CTA (Fig. 4) . Concern has been raised regarding the performance of esophagoscopy in the setting of potential AEF, in which air insufflation into the esophagus could push air or esophageal contents into the left atrium.
The total mortality rate of cases reviewed, with surgical and nonsurgical interventions, was 55.4% (36 total deaths out of 65 total cases). 79.4% of patients with AEF post AF ablation survived after undergoing surgical correction with esophageal repair, compared to 6.5% of patients who were treated with non-surgical interventions. Overall, patients who underwent surgical repair were twelve times more likely to survive than those treated with stenting, antibiotic therapy or no intervention at all [5] . With such a large survival advantage conferred by definitive surgical intervention, we advocate that definitive and prompt surgical intervention should be the standard of care for such a dreaded complication (Fig. 5) .
Limitations
This is a retrospective review of published cases of AEF, and it is likely that many cases of AEF have not been published and so not available to include in this review. It is not possible from these data to assess or compare the incidence of AEF with catheter or surgical ablation. Additionally, there may be important differences between patients who underwent surgical versus non-surgical treatment for AEF which might have impacted the mortality rates of these patients.
Conclusions
Atrioesophageal fistula is an uncommon but adverse event of atrial fibrillation catheter based ablation associated with increased fatality. Patients who underwent surgical repair were twelve times more likely to survive than those treated with stenting, antibiotic therapy or no intervention. Based on the observation that patients are 12 times more likely to survive an AEF with surgery than without, the authors believe that prompt surgical correction of AEF should be considered as standard of care when dealing with this dreaded complication.
